Takeda drug wins first FDA approval in rare, inherited blood clotting disorder

The latest stories trending on MedCity News.

Editor's Pick

Top Story Takeda Drug Wins First FDA Approval in Rare, Inherited Blood Clotting Disorder Takeda Pharmaceutical enzyme replacement drug Adzynma is the first FDA-approved therapy for a rare blood disorder affecting fewer than 1,000 Americans. Our regulatory recap also includes the much-anticipated approval of an Eli Lilly weight loss drug and a crackdown on what the FTC says are improperly listed pharma product patents. Sponsored Content Payer's Place: Shantanu Agrawal of Elevance Health Presented by HLTH and MedCity News Chief Health Officer, Dr. Shantanu Agrawal of Elevance Health discusses health equity and how they are working with community based organizations to optimize access to healthcare.  He also addresses the importance of understanding social needs of patients to provide the best care possible. Watch the full interview here! INVEST 2024 - The Premier National Healthcare Investing Conference Join us to hear from innovative startups, investors, prominent industry players, contrarians and entrepreneurs as they discuss the following topics: Healthcare Industry Embraces Risk Women's Health Sector Matures Investment Trends Employers Jump on the Value-Based Care The Future of Medicare Advantage The Evolution of Precision Medicine How are Glp-1 Drugs Reshaping the Healthcare Industry? Secure Your Extreme Early Bird Savings Seat Now

Featured News

OmniLife Health's Clinical Workflow Solution Focuses on Complex Care OmniLife Health's initial focus with its complex care coordination platform is organ transplant care. Digitizing Healthcare: Can AI Augment Empathy and Compassion in Healthcare? To digitize healthcare and lean on the emerging technologies is to find the opportunity within the relationship between machine and human to augment humans' ability to be human – to empathize and provide the compassionate touch to care. Important Factors Differentiating Prescription Versus OTC Hearing Aids It is important to understand that the performance of over-the-counter hearing aids can vary widely from prescription hearing aids due to a number of factors. A Zip Code Could Determine a Baby's Fate in the NICU and How Technology Can Change That Digital tools like remote monitoring devices, virtual care, and clinical intelligence platforms – all can be leveraged to fill gaps in care in rural hospitals as it relates to care in neonatal intensive care units. In the hands of a collective many, they can be deployed to level the playing field in caring for babies needing special attention and to increase bandwidth and improve adherence to quality guidelines. MedCity FemFwd Podcast: Inside the Women's Health Initiatives Developed by the Orlando VA In this episode, we're joined by Melissa Tran, a marriage and family therapist and the military sexual trauma coordinator at the Orlando VA. She's here to discuss the unique challenges female veterans face and the programs she's helping build for this population.

Resources

MedCity Pivot Podcast: A Conversation with CommonSpirit Health's Population Health Innovation Lead Season 4 of the MedCity Pivot Podcast launches with a focus on health equity and a conversation with Dr. Alisahah Jackson, system vice president of population health innovation and policy at CommonSpirit Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe